Portfolio Holdings Detail for ISIN IE000NITTFF2
Stock Name / Fund | iShares Russell 1000 Growth UCITS ETF USD Acc |
Issuer | Blackrock |
Entity holding fund | iShares VII Public Limited Company |
Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
Entity LEI | 549300Q7FFITMZ2PFZ28 |
ETF Ticker | R1GR(USD) AS |
ETF Ticker | R1GR(USD) Euronext Amsterdam |
Holdings detail for EXEL
Stock Name | Exelixis Inc |
Ticker | EXEL(USD) NASDAQ |
TYPE | Common Stock |
Country | USA |
ISIN | US30161Q1040 |
Show aggregate EXEL holdings
News associated with EXEL
- Oppenheimer & Co. Inc. Takes $561,000 Position in Exelixis, Inc. (NASDAQ:EXEL)
- Oppenheimer & Co. Inc. acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 16,836 shares of the biotechnology company’s stock, valued at approximately $561,000. Other hedge funds also recently modified their holdings of the […] - 2025-03-07 09:07:09
- Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Truist Financial Corp
- Truist Financial Corp grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 31.7% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 18,169 shares of the biotechnology company’s stock after purchasing an additional 4,378 shares during the quarter. Truist Financial Corp’s […] - 2025-03-03 08:20:57
- New York State Common Retirement Fund Trims Holdings in Exelixis, Inc. (NASDAQ:EXEL)
- New York State Common Retirement Fund reduced its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 10.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 157,257 shares of the biotechnology company’s stock after selling 18,460 shares during the quarter. New York […] - 2025-02-28 09:04:55
- Analysts Set Exelixis, Inc. (NASDAQ:EXEL) Price Target at $37.24
- Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twenty analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, eight have given a hold rating and eleven have given a buy rating to the […] - 2025-02-27 06:22:51
- CIBC Asset Management Inc Has $307,000 Stake in Exelixis, Inc. (NASDAQ:EXEL)
- CIBC Asset Management Inc boosted its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 5.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,210 shares of the biotechnology company’s stock after purchasing an additional 452 shares during the […] - 2025-02-25 08:42:59
- Principal Financial Group Inc. Has $22.06 Million Stake in Exelixis, Inc. (NASDAQ:EXEL)
- Principal Financial Group Inc. reduced its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 662,436 shares of the biotechnology company’s stock after selling 3,306 shares during the period. Principal Financial […] - 2025-02-24 08:49:13
- Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by Rhumbline Advisers
- Rhumbline Advisers lessened its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 0.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 827,114 shares of the biotechnology company’s stock after selling 5,657 shares during the period. Rhumbline Advisers’ holdings in Exelixis were worth […] - 2025-02-20 08:54:51
- Blue Trust Inc. Purchases 5,137 Shares of Exelixis, Inc. (NASDAQ:EXEL)
- Blue Trust Inc. grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 84.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 11,231 shares of the biotechnology company’s stock after acquiring an additional 5,137 shares during the quarter. Blue Trust Inc.’s holdings in Exelixis […] - 2025-02-19 10:12:49
- Short Interest in Exelixis, Inc. (NASDAQ:EXEL) Declines By 9.5%
- Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 13,090,000 shares, a decline of 9.5% from the January 15th total of 14,460,000 shares. Approximately 4.7% of the shares of the stock are short sold. Based on an average daily […] - 2025-02-19 06:31:00
- Exelixis, Inc. (NASDAQ:EXEL) Shares Acquired by V Square Quantitative Management LLC
- V Square Quantitative Management LLC increased its stake in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 37.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,563 shares of the biotechnology company’s stock after buying an additional 425 […] - 2025-02-18 09:29:07
- Van ECK Associates Corp Buys 78,740 Shares of Exelixis, Inc. (NASDAQ:EXEL)
- Van ECK Associates Corp lifted its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 45.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 252,324 shares of the biotechnology company’s stock after purchasing an additional 78,740 shares during the period. Van ECK Associates […] - 2025-02-17 08:52:26
- Exelixis, Inc. (NASDAQ:EXEL) Shares Sold by State of Alaska Department of Revenue
- State of Alaska Department of Revenue lowered its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 74.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,561 shares of the biotechnology company’s stock after selling 94,281 shares during the period. State […] - 2025-02-14 10:36:49
- Mirae Asset Global Investments Co. Ltd. Has $322,000 Position in Exelixis, Inc. (NASDAQ:EXEL)
- Mirae Asset Global Investments Co. Ltd. lessened its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 7.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 9,516 shares of the biotechnology company’s stock after selling 801 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Exelixis were worth $322,000 as of […] - 2025-02-14 09:01:04
- Spire Wealth Management Has $300,000 Holdings in Exelixis, Inc. (NASDAQ:EXEL)
- Spire Wealth Management raised its holdings in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 49.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 9,010 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the quarter. Spire Wealth Management’s holdings in Exelixis were worth $300,000 at the end of […] - 2025-02-07 09:04:01
- Chicago Partners Investment Group LLC Takes Position in Exelixis, Inc. (NASDAQ:EXEL)
- Chicago Partners Investment Group LLC purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 7,156 shares of the biotechnology company’s stock, valued at approximately $247,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the […] - 2025-02-05 09:05:02
- Exelixis, Inc. (NASDAQ:EXEL) Receives $36.06 Consensus PT from Analysts
- Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the nineteen brokerages that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and eleven have issued a buy recommendation […] - 2025-02-04 09:13:05
- KBC Group NV Buys 3,332 Shares of Exelixis, Inc. (NASDAQ:EXEL)
- KBC Group NV increased its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 46.4% during the 4th quarter, Holdings Channel reports. The firm owned 10,514 shares of the biotechnology company’s stock after acquiring an additional 3,332 shares during the quarter. KBC Group NV’s holdings in Exelixis were worth $350,000 at the end of the […] - 2025-02-03 09:09:10
- Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, UBS Group Analyst Says
- Exelixis (NASDAQ:EXEL – Get Free Report) had its price target raised by research analysts at UBS Group from $30.00 to $34.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “neutral” rating on the biotechnology company’s stock. UBS Group’s price objective suggests a potential upside of 3.16% from the stock’s current price. […] - 2025-01-30 10:42:55
iShares Russell 1000 Growth UCITS ETF USD Acc EXEL holdings
Date | Number of EXEL Shares Held | Base Market Value of EXEL Shares | Local Market Value of EXEL Shares | Change in EXEL Shares Held | Change in EXEL Base Value | Current Price per EXEL Share Held | Previous Price per EXEL Share Held |
---|
2025-03-10 (Monday) | 1,827 | USD 71,536 | USD 71,536 | 0 | USD 1,050 | USD 39.1549 | USD 38.5802 |
2025-03-07 (Friday) | 1,827 | USD 70,486 | USD 70,486 | 0 | USD -128 | USD 38.5802 | USD 38.6502 |
2025-03-05 (Wednesday) | 1,827 | USD 70,614 | USD 70,614 | 0 | USD 658 | USD 38.6502 | USD 38.2901 |
2025-03-04 (Tuesday) | 1,827 | USD 69,956 | USD 69,956 | 0 | USD -475 | USD 38.2901 | USD 38.5501 |
2025-03-03 (Monday) | 1,827 | USD 70,431 | USD 70,431 | 0 | USD -256 | USD 38.5501 | USD 38.6902 |
2025-02-28 (Friday) | 1,827 | USD 70,687 | USD 70,687 | 0 | USD 1,900 | USD 38.6902 | USD 37.6502 |
2025-02-27 (Thursday) | 1,827 | USD 68,787 | USD 68,787 | 30 | USD 1,346 | USD 37.6502 | USD 37.5298 |
2025-02-26 (Wednesday) | 1,797 | USD 67,441 | USD 67,441 | 0 | USD 1,096 | USD 37.5298 | USD 36.9199 |
2025-02-25 (Tuesday) | 1,797 | USD 66,345 | USD 66,345 | -30 | USD -1,492 | USD 36.9199 | USD 37.1303 |
2025-02-24 (Monday) | 1,827 | USD 67,837 | USD 67,837 | -30 | USD -593 | USD 37.1303 | USD 36.8498 |
2025-02-21 (Friday) | 1,857 | USD 68,430 | USD 68,430 | 0 | USD 3,268 | USD 36.8498 | USD 35.0899 |
2025-02-20 (Thursday) | 1,857 | USD 65,162 | USD 65,162 | 0 | USD 37 | USD 35.0899 | USD 35.07 |
2025-02-19 (Wednesday) | 1,857 | USD 65,125 | USD 65,125 | 0 | USD 1,616 | USD 35.07 | USD 34.1998 |
2025-02-18 (Tuesday) | 1,857 | USD 63,509 | USD 63,509 | 0 | USD -1,486 | USD 34.1998 | USD 35 |
2025-02-17 (Monday) | 1,857 | USD 64,995 | USD 64,995 | 0 | USD 0 | USD 35 | USD 35 |
2025-02-14 (Friday) | 1,857 | USD 64,995 | USD 64,995 | 0 | USD 947 | USD 35 | USD 34.49 |
2025-02-13 (Thursday) | 1,857 | USD 64,048 | USD 64,048 | 0 | USD 3,138 | USD 34.49 | USD 32.8002 |
2025-02-12 (Wednesday) | 1,857 | USD 60,910 | USD 60,910 | 0 | USD -18 | USD 32.8002 | USD 32.8099 |
2025-02-11 (Tuesday) | 1,857 | USD 60,928 | USD 60,928 | 0 | USD -1,282 | USD 32.8099 | USD 33.5003 |
2025-02-10 (Monday) | 1,857 | USD 62,210 | USD 62,210 | 0 | USD 38 | USD 33.5003 | USD 33.4798 |
2025-02-07 (Friday) | 1,857 | USD 62,172 | USD 62,172 | 0 | USD -353 | USD 33.4798 | USD 33.6699 |
2025-02-06 (Thursday) | 1,857 | USD 62,525 | USD 62,525 | 29 | USD 1,196 | USD 33.6699 | USD 33.5498 |
2025-02-05 (Wednesday) | 1,828 | USD 61,329 | USD 61,329 | 29 | USD 1,746 | USD 33.5498 | USD 33.1201 |
2025-02-04 (Tuesday) | 1,799 | USD 59,583 | USD 59,583 | 0 | USD 432 | USD 33.1201 | USD 32.8799 |
2025-02-03 (Monday) | 1,799 | USD 59,151 | USD 59,151 | 0 | USD -486 | USD 32.8799 | USD 33.1501 |
2025-01-31 (Friday) | 1,799 | USD 59,637 | USD 59,637 | 0 | USD 396 | USD 33.1501 | USD 32.93 |
2025-01-30 (Thursday) | 1,799 | USD 59,241 | USD 59,241 | 0 | USD -54 | USD 32.93 | USD 32.96 |
2025-01-29 (Wednesday) | 1,799 | USD 59,295 | USD 59,295 | 0 | USD 648 | USD 32.96 | USD 32.5998 |
2025-01-28 (Tuesday) | 1,799 | USD 58,647 | USD 58,647 | 0 | USD -234 | USD 32.5998 | USD 32.7299 |
2025-01-27 (Monday) | 1,799 | USD 58,881 | USD 58,881 | 0 | USD 629 | USD 32.7299 | USD 32.3802 |
2025-01-24 (Friday) | 1,799 | USD 58,252 | USD 58,252 | 0 | USD -3,148 | USD 32.3802 | USD 34.1301 |
2025-01-23 (Thursday) | 1,799 | USD 61,400 | USD 61,400 | 0 | USD 2,249 | USD 34.1301 | USD 32.8799 |
2025-01-22 (Wednesday) | 1,799 | USD 59,151 | USD 59,151 | | | | |
2025-01-21 (Tuesday) | 1,741 | USD 63,425 | USD 63,425 | | | | |
2025-01-20 (Monday) | 1,625 | USD 58,825 | USD 58,825 | | | | |
2025-01-17 (Friday) | 1,625 | USD 58,825 | USD 58,825 | | | | |
2025-01-16 (Thursday) | 1,625 | USD 59,394 | USD 59,394 | | | | |
2025-01-15 (Wednesday) | 1,538 | USD 57,321 | USD 57,321 | | | | |
2025-01-14 (Tuesday) | 1,538 | USD 54,830 | USD 54,830 | | | | |
2025-01-13 (Monday) | 1,538 | USD 54,291 | USD 54,291 | | | | |
2025-01-10 (Friday) | 1,538 | USD 55,399 | USD 55,399 | | | | |
2025-01-09 (Thursday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2025-01-09 (Thursday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2025-01-09 (Thursday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2025-01-08 (Wednesday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2025-01-08 (Wednesday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2025-01-08 (Wednesday) | 1,538 | USD 53,061 | USD 53,061 | | | | |
2024-12-10 (Tuesday) | 1,364 | USD 48,054 | USD 48,054 | 30 | USD 1,137 | USD 35.2302 | USD 35.1702 |
2024-12-09 (Monday) | 1,334 | USD 46,917 | USD 46,917 | 30 | USD 208 | USD 35.1702 | USD 35.8198 |
2024-12-06 (Friday) | 1,304 | USD 46,709 | USD 46,709 | 0 | USD -287 | USD 35.8198 | USD 36.0399 |
2024-12-05 (Thursday) | 1,304 | USD 46,996 | USD 46,996 | 0 | USD 352 | USD 36.0399 | USD 35.7699 |
2024-12-04 (Wednesday) | 1,304 | USD 46,644 | USD 46,644 | 0 | USD 665 | USD 35.7699 | USD 35.26 |
2024-12-03 (Tuesday) | 1,304 | USD 45,979 | USD 45,979 | 0 | USD -430 | USD 35.26 | USD 35.5897 |
2024-12-02 (Monday) | 1,304 | USD 46,409 | USD 46,409 | -30 | USD -2,229 | USD 35.5897 | USD 36.4603 |
2024-11-29 (Friday) | 1,334 | USD 48,638 | USD 48,638 | 0 | USD 707 | USD 36.4603 | USD 35.9303 |
2024-11-28 (Thursday) | 1,334 | USD 47,931 | USD 47,931 | 0 | USD 0 | USD 35.9303 | USD 35.9303 |
2024-11-27 (Wednesday) | 1,334 | USD 47,931 | USD 47,931 | 0 | USD -693 | USD 35.9303 | USD 36.4498 |
2024-11-26 (Tuesday) | 1,334 | USD 48,624 | USD 48,624 | 0 | USD 93 | USD 36.4498 | USD 36.3801 |
2024-11-25 (Monday) | 1,334 | USD 48,531 | USD 48,531 | 29 | USD 2,060 | USD 36.3801 | USD 35.61 |
2024-11-22 (Friday) | 1,305 | USD 46,471 | USD 46,471 | 0 | USD 1,018 | USD 35.61 | USD 34.8299 |
2024-11-21 (Thursday) | 1,305 | USD 45,453 | USD 45,453 | 0 | USD 235 | USD 34.8299 | USD 34.6498 |
2024-11-20 (Wednesday) | 1,305 | USD 45,218 | USD 45,218 | 0 | USD 313 | USD 34.6498 | USD 34.41 |
2024-11-19 (Tuesday) | 1,305 | USD 44,905 | USD 44,905 | 0 | USD -144 | USD 34.41 | USD 34.5203 |
2024-11-18 (Monday) | 1,305 | USD 45,049 | USD 45,049 | 0 | USD -1,735 | USD 34.5203 | USD 35.8498 |
2024-11-12 (Tuesday) | 1,305 | USD 46,784 | USD 46,784 | 0 | USD -522 | USD 35.8498 | USD 36.2498 |
2024-11-08 (Friday) | 1,305 | USD 47,306 | USD 47,306 | 87 | USD 3,702 | USD 36.2498 | USD 35.7997 |
2024-11-07 (Thursday) | 1,218 | USD 43,604 | USD 43,604 | 0 | USD 353 | USD 35.7997 | USD 35.5099 |
2024-11-06 (Wednesday) | 1,218 | USD 43,251 | USD 43,251 | 29 | USD 1,909 | USD 35.5099 | USD 34.7704 |
2024-11-05 (Tuesday) | 1,189 | USD 41,342 | USD 41,342 | 0 | USD 571 | USD 34.7704 | USD 34.2902 |
2024-11-04 (Monday) | 1,189 | USD 40,771 | USD 40,771 | 0 | USD 202 | USD 34.2902 | USD 34.1203 |
2024-11-01 (Friday) | 1,189 | USD 40,569 | USD 40,569 | 0 | USD 1,094 | USD 34.1203 | USD 33.2002 |
2024-10-31 (Thursday) | 1,189 | USD 39,475 | USD 39,475 | 0 | USD 904 | USD 33.2002 | USD 32.4399 |
2024-10-30 (Wednesday) | 1,189 | USD 38,571 | USD 38,571 | 29 | USD 5,244 | USD 32.4399 | USD 28.7302 |
2024-10-29 (Tuesday) | 1,160 | USD 33,327 | USD 33,327 | 0 | USD 267 | USD 28.7302 | USD 28.5 |
2024-10-28 (Monday) | 1,160 | USD 33,060 | USD 33,060 | 0 | USD 731 | USD 28.5 | USD 27.8698 |
2024-10-25 (Friday) | 1,160 | USD 32,329 | USD 32,329 | 0 | USD -279 | USD 27.8698 | USD 28.1103 |
2024-10-24 (Thursday) | 1,160 | USD 32,608 | USD 32,608 | 0 | USD -243 | USD 28.1103 | USD 28.3198 |
2024-10-23 (Wednesday) | 1,160 | USD 32,851 | USD 32,851 | 0 | USD -592 | USD 28.3198 | USD 28.8302 |
2024-10-22 (Tuesday) | 1,160 | USD 33,443 | USD 33,443 | -630 | USD -17,858 | USD 28.8302 | USD 28.6598 |
2024-10-21 (Monday) | 1,790 | USD 51,301 | USD 51,301 | 0 | USD -430 | USD 28.6598 | USD 28.9 |
2024-10-18 (Friday) | 1,790 | USD 51,731 | USD 51,731 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of EXEL by Blackrock for IE000NITTFF2
Show aggregate share trades of EXELDate | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
---|
2025-02-27 | BUY | 30 | | | 37.650* | | 33.95 |
2025-02-25 | SELL | -30 | | | 36.920* | | 33.84 Profit of 1,015 on sale |
2025-02-24 | SELL | -30 | | | 37.130* | | 33.78 Profit of 1,013 on sale |
2025-02-06 | BUY | 29 | | | 33.670* | | 33.62 |
2025-02-05 | BUY | 29 | | | 33.550* | | 33.62 |
2024-12-10 | BUY | 30 | | | 35.230* | | 33.75 |
2024-12-09 | BUY | 30 | | | 35.170* | | 33.71 |
2024-12-02 | SELL | -30 | | | 35.590* | | 33.32 Profit of 1,000 on sale |
2024-11-25 | BUY | 29 | | | 36.380* | | 32.63 |
2024-11-08 | BUY | 87 | | | 36.250* | | 31.37 |
2024-11-06 | BUY | 29 | | | 35.510* | | 30.65 |
2024-10-30 | BUY | 29 | | | 32.440* | | 28.43 |
2024-10-22 | SELL | -630 | | | 28.830* | | 28.66 Profit of 18,056 on sale |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of EXEL
Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
---|
2025-03-11 | 460,061 | 3,937 | 1,178,100 | 39.1% |
2025-03-10 | 937,773 | 515 | 1,456,762 | 64.4% |
2025-03-07 | 486,400 | 501 | 681,444 | 71.4% |
2025-03-06 | 450,427 | 506 | 789,901 | 57.0% |
2025-03-05 | 490,279 | 1,031 | 741,947 | 66.1% |
2025-03-04 | 741,320 | 417 | 1,194,954 | 62.0% |
2025-03-03 | 841,360 | 96 | 1,303,121 | 64.6% |
2025-02-28 | 765,367 | 48,621 | 1,172,514 | 65.3% |
2025-02-27 | 481,834 | 24,070 | 790,490 | 61.0% |
2025-02-26 | 278,435 | 3,187 | 683,589 | 40.7% |
2025-02-25 | 314,436 | 5,770 | 786,198 | 40.0% |
2025-02-24 | 539,414 | 22,590 | 1,315,325 | 41.0% |
2025-02-21 | 620,123 | 3,100 | 1,593,926 | 38.9% |
2025-02-20 | 279,445 | 755 | 683,731 | 40.9% |
2025-02-19 | 355,938 | 897 | 950,210 | 37.5% |
2025-02-18 | 319,654 | 2,737 | 813,447 | 39.3% |
2025-02-14 | 322,308 | 49,475 | 877,869 | 36.7% |
2025-02-13 | 503,792 | 14,671 | 1,200,655 | 42.0% |
2025-02-12 | 868,796 | 1,884 | 1,826,006 | 47.6% |
2025-02-11 | 559,373 | 10 | 926,828 | 60.4% |
2025-02-10 | 585,567 | 1,087 | 868,857 | 67.4% |
2025-02-07 | 344,552 | 124 | 487,481 | 70.7% |
2025-02-06 | 254,118 | 100 | 406,748 | 62.5% |
2025-02-05 | 284,481 | 1,037 | 501,994 | 56.7% |
2025-02-04 | 232,368 | 53 | 486,829 | 47.7% |
2025-02-03 | 234,321 | 2,664 | 673,870 | 34.8% |
2025-01-31 | 317,285 | 77 | 576,054 | 55.1% |
2025-01-30 | 412,239 | 1 | 662,708 | 62.2% |
2025-01-29 | 344,445 | 929 | 555,653 | 62.0% |
2025-01-28 | 415,538 | 509 | 647,283 | 64.2% |
2025-01-27 | 649,687 | 255 | 1,167,003 | 55.7% |
2025-01-24 | 782,008 | 709 | 1,308,944 | 59.7% |
2025-01-23 | 239,241 | 4,822 | 828,924 | 28.9% |
2025-01-22 | 917,734 | 9,720 | 1,440,785 | 63.7% |
2025-01-21 | 467,459 | 1,099 | 722,906 | 64.7% |
2025-01-17 | 330,975 | 4,460 | 566,102 | 58.5% |
2025-01-16 | 308,031 | 0 | 526,004 | 58.6% |
2025-01-15 | 438,346 | 8,510 | 772,078 | 56.8% |
2025-01-14 | 369,318 | 294 | 603,957 | 61.1% |
2025-01-13 | 522,884 | 0 | 869,848 | 60.1% |
2025-01-10 | 764,809 | 276 | 1,090,906 | 70.1% |
2025-01-08 | 280,734 | 150 | 496,942 | 56.5% |
2025-01-07 | 426,152 | 317 | 894,221 | 47.7% |
2025-01-06 | 436,941 | 72 | 808,397 | 54.1% |
2025-01-03 | 269,246 | 1,272 | 389,927 | 69.1% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.